SCHEMBL25456385

SCHEMBL25456385

Cc1ccccc1-n1c2ccccc2c2ccc(C)c(C)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.47
FTO Q9C0B1 1/20 0.47
TSHR P16473 2/20 0.44
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SYK P43405 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
RAB9A P51151 1/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
APEX1 P27695 1/20 0.40
RECQL P46063 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2A6 P11509 1/20 0.37
GPR3 P46089 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25465317 0.85 ALKBH5 (0.44) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL25456383 0.84 SYK (0.42) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL17995394 0.84 ALKBH5 (0.61) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL6552455 0.83 TSHR (0.53) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL23225742 0.81 L3MBTL1 (0.55) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL25456390 0.81 ALKBH5 (0.42) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL20685525 0.78 ALKBH5 (0.48) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL11926712 0.78 ALKBH5 (0.50) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL21446133 0.77 TSHR (0.47) ALKBH5FTOTSHRALDH1A1SMN1; SMN2
SCHEMBL16644620 0.77 ALKBH5 (0.67) ALKBH5FTOTSHRALDH1A1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-16 US disclosed
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-01 US disclosed
US-20230146345-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP ALKBH5 412/4885FTO 58/4885TSHR 3056/4885
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, OPRD1, OXSR1 ALKBH5 3251/4885FTO 707/4885TSHR 159/4885
US-20230146345-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LAGE3, ERCC1, DDT ALKBH5 2479/4885FTO 594/4885TSHR 2573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.